# Pfizer Inc: Form 8-K, filed May 2, 2023

- Company: [Pfizer Inc](/companies/pfe.md) (CIK 78003)
- Form: 8-K
- Filed: 2023-05-02
- Accepted by EDGAR: May 2, 2023, 08:05 ET
- Period: 2023-05-02
- Accession: 0001628280-23-014759
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/78003/000162828023014759/pfe-20230502.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/78003/000162828023014759/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/78003/000162828023014759/pfe-20230502.htm

Filed May 2, 2023.
Source: SEC EDGAR, the filing index for accession 0001628280-23-014759. Last ingested by Listed: Nov 12, 2026, 18:08 ET. No prices; not investment advice.
